|
Mr. Perry is the Co-founder of KPL, which was founded to commercialize immunoreagents for the diagnostic market. Mr. Perry worked in various roles during the last twenty years, including finance, sales and market identification. Mr. Perry initiated export of KPL products internationally by establishing a network of distributors and the creation of the European office.
Mr. Perry repositioned the Company for growth by attracting to KPL a professional management team and has redirected KPL business in the life science research market. By divesting its veterinary diagnostic business and focusing on the life science research business and introducing products for the molecular biology research market area which lead to the adding proprietary products for the genomic research market.
Prior to starting KPL, Mr. Perry was with Litton Bionetics managing a National Cancer Institute contract and was responsible for the production of various biologicals for cancer research. From 1972 to 1979, Mr. Perry held various managerial positions in operations and R&D within Frederick Cancer Research Center. Mr. Perry holds a Masters Degree in Science from State University of New York at Buffalo and has been an active member of TEC, an International organization for CEO’s. | 